Roche
ROG.SW
$239.65
Share price
-1.53%
Change (1 day)
-24.59%
Change (1 year)
Categories
Roche (ROG.SW) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $68.03 B
According to Roche's latest financial reports the company's total liabilities are $68.03 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Roche - Total liabilities on balance sheet (from 2006 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $68.03 B | 11.97% |
| 2022-12-31 | $60.76 B | -13.21% |
| 2021-12-31 | $70.01 B | 33.12% |
| 2020-12-31 | $52.59 B | 7.88% |
| 2019-12-31 | $48.75 B | -0.41% |
| 2018-12-31 | $48.95 B | -0% |
| 2017-12-31 | $48.95 B | -1.08% |
| 2016-12-31 | $49.49 B | -6.8% |
| 2015-12-31 | $53.10 B | -2.76% |
| 2014-12-31 | $54.60 B | 18.38% |
| 2013-12-31 | $46.12 B | -12.4% |
| 2012-12-31 | $52.66 B | 4.94% |
| 2011-12-31 | $50.18 B | -4.99% |
| 2010-12-31 | $52.81 B | -16.16% |
| 2009-12-31 | $62.99 B | 195.05% |
| 2008-12-31 | $21.35 B | -3.02% |
| 2007-12-31 | $22.01 B | -2.95% |
| 2006-12-31 | $22.68 B | 2.8% |
| 2005-12-31 | $22.06 B | 0.02% |
| 2004-12-31 | $22.06 B | -10.02% |
| 2003-12-31 | $24.52 B | -41.44% |
| 2002-12-31 | $41.87 B | -7.72% |
| 2001-12-31 | $45.37 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 45.19% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | -21.82% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 101.67% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | -49.46% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 33.63% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | -15.32% | 🇫🇷 France |
 Becton Dickinson BDX | $26.94 B | -60.40% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 1.47% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | -13.54% | 🇬🇧 UK |